CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,470,252 | +120106.9% | 1,593,711 | +5.5% | 0.08% | +13.4% |
| Q3 2022 | $2,055 | -32.2% | 1,511,029 | +9.2% | 0.07% | -35.6% |
| Q2 2022 | $3,031 | -21.9% | 1,384,014 | +13.8% | 0.10% | +8.3% |
| Q1 2022 | $3,879 | -16.3% | 1,215,928 | +10.0% | 0.10% | +1.1% |
| Q4 2021 | $4,632 | -50.6% | 1,105,607 | -4.2% | 0.10% | -46.6% |
| Q3 2021 | $9,375 | +23.7% | 1,154,561 | +15.0% | 0.18% | +26.2% |
| Q2 2021 | $7,577 | -4.3% | 1,003,546 | +10.0% | 0.14% | -16.1% |
| Q1 2021 | $7,917 | +23.0% | 912,154 | +12.9% | 0.17% | +16.7% |
| Q4 2020 | $6,437 | +27.7% | 807,699 | +27.8% | 0.14% | -15.8% |
| Q3 2020 | $5,040 | -13.6% | 632,035 | +7.2% | 0.17% | -19.0% |
| Q2 2020 | $5,836 | +9.2% | 589,483 | -14.7% | 0.21% | -26.7% |
| Q1 2020 | $5,342 | +104.4% | 691,130 | +1.8% | 0.29% | +140.0% |
| Q4 2019 | $2,613 | -21.8% | 678,618 | +2.1% | 0.12% | -34.8% |
| Q3 2019 | $3,343 | +27.7% | 664,704 | +67.9% | 0.18% | +42.6% |
| Q2 2019 | $2,617 | +6.2% | 395,875 | +21.6% | 0.13% | -2.3% |
| Q1 2019 | $2,465 | +9.7% | 325,652 | +17.1% | 0.13% | -17.0% |
| Q4 2018 | $2,248 | -7.0% | 278,170 | +48.5% | 0.16% | +21.4% |
| Q3 2018 | $2,416 | – | 187,300 | – | 0.13% | – |
Download | ||||||